Inventor · disambiguated record
Marvin J. Meyers
Also filed as: MEYERS MARVIN · MEYERS MARVIN J · MEYERS MARVIN JAY
9 granted patents·29 pending applications·13 citations·filing 2003–2022
80Inventor score
Files withPFIZER16UNIV SAINT LOUIS11PHARMACIA CORP5ARHANCET GRACIELA BARBIERI1FIMBRION THERAPEUTICS INC1
Top patents by PatentIndex Score
38 records- 0182US8044052B2Biaryl ether urea compoundsPFIZER·Filed 2007·Granted Oct 25, 2011·8 cites·10 claims
- 0275US11098072B2Alkenyl and beta-substituted phosphonates as antimicrobial agentsUNIV GEORGE WASHINGTON·Filed 2018·Granted Aug 24, 2021·2 cites·22 claims
- 0373US10980754B2Anti-fungal compoundsUNIV SAINT LOUIS·Filed 2017·Granted Apr 20, 2021·1 cites·19 claims
- 0470US10463664B2Inhibitors of HSV nucleotidyl transferases and uses thereforUNIV SAINT LOUIS·Filed 2014·Granted Nov 5, 2019·2 cites·15 claims
- 0567US2020039960A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2019·Application pending·0 cites
- 0666US11191754B2Inhibitors of nucleotidyl transferases and uses in herpes and hepatitis viral infections thereforUNIV SAINT LOUIS·Filed 2019·Granted Dec 7, 2021·0 cites·13 claims
- 0765US2019144429A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2019·Application pending·0 cites
- 0864US2005143371A1Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitorsPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 0963US7781428B2Pyrazoline compoundsPFIZER·Filed 2007·Granted Aug 24, 2010·0 cites·18 claims
- 1063US2016046597A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2014·Application pending·0 cites
- 1163US2005137220A1Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitorsPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1263US2018282304A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2018·Application pending·0 cites
- 1362US2018086736A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2017·Application pending·0 cites
- 1460US2017233371A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2017·Application pending·0 cites
- 1556US2008113971A1Pyrazole compounds as protein kinase inhibitorsHANAU CATHLEEN E·Filed 2007·Application pending·0 cites
- 1653US2004209897A1Mitogen activated protein kinase-activated protein kinase-2 inhibiting compoundsPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 1753US2004152739A1Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2PHARMACIA CORP·Filed 2003·Application pending·0 cites
- 1852US2012035131A1Pyrazoline compoundsMEYERS MARVIN J·Filed 2011·Application pending·0 cites
- 1952US2005101623A1Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitorsPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2051US9353089B2Compositions and methods for the treatment of malariaUNIV SAINT LOUIS·Filed 2014·Granted May 31, 2016·0 cites·8 claims
- 2151US2011230493A11-OXA-8-Azaspiro [4,5] Decabe-8-Carboxamide Compounds as FAAH InhibitorsPFIZER·Filed 2009·Application pending·0 cites
- 2250US2011053949A14-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitorsPFIZER·Filed 2009·Application pending·0 cites
- 2350US2010113465A17-azaspiro[3.5]nonane-7-carboxamide compoundsPFIZER·Filed 2009·Application pending·0 cites
- 2449US2011060012A14-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitorsPFIZER·Filed 2009·Application pending·0 cites
- 2549US2011053950A14-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitorsPFIZER·Filed 2009·Application pending·0 cites
- 2649US2023212172A1Arylacetamide analogs of piperazine-[1,2,4]triazolo[4,3-b]pyridazinesUNIV OF VERMONT AND STATE AGRICULTURAL COLLEGE·Filed 2021·Application pending·0 cites
- 2749US2018169083A1Inhibitors of nucleotidyl transferases and use in herpes and hepatitis viral infections thereforUNIV SAINT LOUIS·Filed 2016·Application pending·0 cites
- 2849US2010280016A1Pyrazoline compoundsPFIZER·Filed 2010·Application pending·0 cites
- 2948US2011053982A1Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitorsPFIZER·Filed 2009·Application pending·0 cites
- 3048US2024279236A1Compounds and methods of treating tuberculosisFIMBRION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3148US2011144159A1Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitorsPFIZER·Filed 2009·Application pending·0 cites
- 3246US12502362B2Inhibitors of nucleotidyltransferase superfamily enzymes as antibioticsUNIV SAINT LOUIS·Filed 2018·Granted Dec 23, 2025·0 cites·12 claims
- 3342US2022079951A1Bet inhibitors for modulating dux4 expression in fshdUNIV SAINT LOUIS·Filed 2019·Application pending·0 cites
- 3442US2019328706A1Compositions comprising an integrin inhibitor and agents which interact with a chemokine and methods of use thereofUNIV SAINT LOUIS·Filed 2019·Application pending·0 cites
- 3540US2022117968A1Thieno[2,3-d)pyrimidines and benzofuro(3,2-d)pyrimidines as antimicrobial agentsUNIV SAINT LOUIS·Filed 2018·Application pending·0 cites
- 3640US2020297696A1P38 inhibitors for the treatment of fshdUNIV SAINT LOUIS·Filed 2018·Application pending·0 cites
- 3739US11358994B2Fatty acid modified human epidermal growth factorUNIV SAINT LOUIS·Filed 2018·Granted Jun 14, 2022·0 cites·2 claims
- 3835US2012022058A14,5-dihydro-1h-pyrazole compounds and their pharmaceutical usesARHANCET GRACIELA BARBIERI·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →